Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study
Author:
Patrice Chevallier,Nelly Robillard,Aude Charbonnier,Emmanuel Raffoux,Sébastien Maury,Sylvain Carras,Cecile Chabrot,Cecile Fohrer,Marc Bernard,Jean-Sebastien Blade,Anne Etienne,Pascaline Talmant,Jacques Delaunay,Thierry Guillaume,Mohamad Mohty et al.
Copyright © 2011 American Society of Hematology